Image
News banner
* Award The EpiRNA-Seq Core Facility obtains the national IBiSA pre-labeling

The EpiRNA-Seq Core Facility renowned in epitranscriptomics has just been rewarded by the national IBiSA network which supports the innovation of platforms in agronomy, biology and health in France and finances original advanced technologies availables to the scientific community. Back on this labeling ...

IBiSA is a national multi-supervisory infrastructure (CEA, CNRS, Inra, Inria, INSERM) which supports research infrastructures developing innovative technologies and which meet a certain number of criteria such as:

  • Original innovative technology(s)
  • Open to outside teams wishing to access the services of the platform
  • Formal display of the service offer, access conditions and prices
  • Implementation of a quality management system inspired by the ISO9001 standard
  • Active technological watch to ensure the sustainability of its technological performance
  • Training actions, ...

The Epitranscriptomic and Sequencing Core Facility (EpiRNA-Seq) has just been pre-labeled by IBiSA for its unique expertise in the manipulation of RNAs and its methodological approaches to identify and quantify the modified nucleotides within RNAs (epitranscriptomics). The EpiRNA-Seq Core Facility joins the national IBiSA network made up of more than 180 platforms with different areas of expertise: Animal facilities and functional exploration, Bioinformatics, Structural Biology and Biophysics, Screening and Chemistry, Plant Experimentation, Genomics, Transcriptomics, Histology Anatomopathology, Cell Imaging, Imaging in vivo, Metabolomics, New Therapies - Vectorization - Stem Cells, Proteomics.

The EpiRNA-Seq Core Facility supports epitranscriptomic projects on several types of modifications (Nm, m7G, m3C). The chemical treatment of RNA combined with Illumina-type sequencing and exclusive bioinformatics pipelines adapted for each project and constantly improved, guarantee users high-performance and high-quality data.

In addition, the Core Facility continues to develop new innovative research approaches to detect other types of modified nucleotides in order to make them available to the scientific community as quickly as possible. The platform also offers two training sessions per year on the theme of epitranscriptomics.

To get more information : https://www.ibisa.net/